Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bloomage BioTechnologySHSE:688363 -0.48%94 Days Payable is 217.24 as of Mar. 2026, which is 43% above its 10-year median of 152.00. GuruFocus rates SHSE:688363 with a GF Score™ of 94/100 and a GF Value™ of ¥42.75 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 1,554 Chemicals companies, Bloomage BioTechnology ranks better than 92.28% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688363 vs LIN, SHW, ECL: Days Payable Comparison
For the Specialty Chemicals subindustry, Bloomage BioTechnology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bloomage BioTechnology Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bloomage BioTechnology's Days Payable distribution charts can be found below:
* The bar in red indicates where Bloomage BioTechnology's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bloomage BioTechnology's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bloomage BioTechnology (SHSE:688363) has a Days Payable of 217.24 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bloomage BioTechnology and its competitors. This is 43% above median its historical median of 152.00. Over the past decade, Bloomage BioTechnology's Days Payable has ranged from 74.40 to 217.97. According to the industry distribution chart, Bloomage BioTechnology ranks #120 out of 1554 companies in the Chemicals industry, placing it in the top 7.7%.
Is Bloomage BioTechnology's Days Payable too high?
Bloomage BioTechnology's current Days Payable of 217.24 is 43% above median its 10-year median of 152.00. Over the past 10 years, this metric has ranged from a low of 74.40 to a high of 217.97. The Chemicals industry median Days Payable is 59.57. Bloomage BioTechnology's value of 217.24 is 264.7% above this industry median. Based on the distribution chart, Bloomage BioTechnology ranks #120 out of 1554 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Bloomage BioTechnology has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bloomage BioTechnology's Days Payable compare to LIN and SHW?
According to the Chemicals industry distribution chart, Bloomage BioTechnology ranks #120 out of 1554 companies for Days Payable. This places Bloomage BioTechnology in the top 8% of its industry — outperforming the majority of peers. The industry median Days Payable is 59.57. Bloomage BioTechnology's value of 217.24 is 264.7% above this benchmark. Historically, Bloomage BioTechnology's own Days Payable has ranged from 74.40 to 217.97 over the past decade. While the company's 10-year median is 152.00 vs. the industry median of 59.57, Bloomage BioTechnology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.57, based on 1,554 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bloomage BioTechnology's current Days Payable of 217.24 is 264.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bloomage BioTechnology and its competitors. For the Chemicals industry, the median Days Payable is 59.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bloomage BioTechnology's current Days Payable is 217.24, which is 43% above median its own 10-year median of 152.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bloomage BioTechnology stock overvalued right now?
Based on GuruFocus' analysis, Bloomage BioTechnology (SHSE:688363) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥42.75, compared to a current price of ¥37.37 — trading 12.6% below its estimated fair value. The current Days Payable is 217.24, which is 43% above median its 10-year median of 152.00 and 264.7% above the Chemicals industry median of 59.57. Bloomage BioTechnology's overall GF Score™ is 94/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bloomage BioTechnology (SHSE:688363), the current Days Payable is 217.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bloomage BioTechnology (SHSE:688363) Overvalued in 2026?
Based on GuruFocus' analysis, Bloomage BioTechnology stock appears to be undervalued.
The current stock price of ¥37.37 is trading 12.6% below its estimated GF Value™ of ¥42.75.
GuruFocus considers Bloomage BioTechnology to be Modestly Undervalued.
Key valuation signals for SHSE:688363:
Days Payable: 217.24 (43% above median its 10-year median of 152.00)
GF Value™: ¥42.75 vs. price of ¥37.37 (12.6% below fair value)
Industry Position: 264.7% above the Chemicals median (#120 of 1554)
No single metric tells the full story. See the SHSE:688363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid or sodium hyaluronic acid. The company's products include raw materials, medical products, functional skincare, and functional foods. Raw materials, mainly hyaluronic acid, are used in pharmaceuticals, medical devices, cosmetics, and food. Medical products span beauty and therapeutic uses, such as viscoelastics, lubricants, fillers, and skin protectors. Skincare items include lotions, creams, and masks, while functional foods feature hyaluronic acid drinks and supplements.
94GF Score
Get the complete analysis for SHSE:688363
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688363 has been successfully added to your 
